QuickView for establishment of integrated proviral latency (biogroup)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
2. L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
4. L1000 CMAP - Umbilical vein endothelial HUVEC cells treated with small molecule perturbagens
5. L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens

1. A neutralization assay for HIV-2 based on measurement of provirus integration by duplex real-time PC…
2. Activation of an oncogenic microRNA cistron by provirus integration.
3. Rapid detection of feline leukemia virus provirus integration into feline genomic DNA.
4. Lessons Learned from Mouse Mammary Tumor Virus in Animal Models.
5. Bovine leukemia virus integration site selection in cattle that develop leukemia.

There were no clinical trials for establishment of integrated proviral latency